Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Despite recent progress in the treatment, the outcome of adult acute T-cell lymphoblastic leukemia (T-ALL) is poor. Development of novel approach to combat this disease is urgently required. Vorinostat, a pan-histone deacetylase (HDAC) inhibitor, exerts promising anticancer activity in a variety of solid and hematologic malignancies. However, the efficacy of vorinostat monotherapy is unsatisfactory. Here, we show that quinacrine (QC), an anti-malaria drug with potent autophagy inhibitory activity, could synergistically enhance vorinostat-induced cell death at a non-toxic concentration. Compared to the single treatment, QC plus vorinostat significantly induced apoptosis, disrupted the mitochondrial transmembrane potential, and decreased Mcl-1 and Bcl-2/Bax ratio. Interestingly, the application of QC plus vorinostat resulted in mitophagy blockade, as reflected by the increase in the K63-linked ubiquitination of mitochondria protein and the formation of mitochondrial aggresomes. QC plus vorinostat markedly increased the reactive oxygen species (ROS) level in cells. Moreover, the ROS scavenger N-acetylcysteine (NAC) abrogated QC plus vorinostat-induced ROS, decreased the ubiquitination of mitochondria proteins, and cell death. Finally, using a xenograft mouse model, we demonstrated that QC plus vorinostat significantly reduced cell proliferation and induced cell death in vivo. Taken together, our results showed that the combination of QC with vorinostat may represent a novel regimen for the treatment of T-cell acute lymphoblastic leukemia, which deserves clinical evaluation in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It induces cell apoptosis in one T cell leukemia cell line in vitro71, and improves the outcome of acute T cell lymphoblastic leukemia in animal models72.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Inhibition of Macroautophagy Triggers Apoptosis
Boya, P., González-Polo, R.-A., Casares, N., Perfettini, J.-L., Dessen, P., Larochette, N., Métivier, D., Meley, D., Souquere, S., Yoshimori, T., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1025-1040.2005 · Cited by 1,625
Selective degradation of mitochondria by mitophagy
Kim, I., Rodriguez-Enriquez, S., & Lemasters, J. J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.034 · Cited by 1,558
Ordureau, A., Sarraf, S. A., Duda, D. M., Heo, J.-M., Jedrychowski, M. P., Sviderskiy, V. O., Olszewski, J. L., Koerber, J. T., Xie, T., Beausoleil, S. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.007 · Cited by 697
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Tan, J., Cang, S., Ma, Y., Petrillo, R. L., & Liu, D. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-5 · Cited by 425
Aitken, R. J., Fisher, H. M., Fulton, N., Gomez, E., Knox, W., Lewis, B., & Irvine, S. (1997) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199708)47:4<468::aid-mrd14>3.0.co;2-s · Cited by 305
Versatile Roles of K63-Linked Ubiquitin Chains in Trafficking
Erpapazoglou, Z., Walker, O., & Haguenauer-Tsapis, R. (2014) · Cells · doi:10.3390/cells3041027 · Cited by 215
Mitochondrial quality control by the ubiquitin–proteasome system
Taylor, E. B., & Rutter, J. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391509 · Cited by 180
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
Golden, E. B., Cho, H.-Y., Hofman, F. M., Louie, S. G., Schönthal, A. H., & Chen, T. C. (2015) · Neurosurgical Focus · doi:10.3171/2014.12.focus14748 · Cited by 178
Impact of Aging and Exercise on Mitochondrial Quality Control in Skeletal Muscle
Kim, Y., Triolo, M., & Hood, D. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3165396 · Cited by 158
Cited by
Repurposing quinacrine for treatment-refractory cancer
Oien, D. B., Pathoulas, C. L., Ray, U., Thirusangu, P., Kalogera, E., & Shridhar, V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.021 · Cited by 87
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Karagiannis, D., & Rampias, T. N. (2021) · Cancers · doi:10.3390/cancers13143575 · Cited by 95
Role of K63-linked ubiquitination in cancer
Cao, L., Liu, X., Zheng, B., Xing, C., & Liu, J. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01204-0 · Cited by 84
“Vorinostat and quinacrine increase intracellular ROS and promote the accumulation of K63-linked ubiquitination of the mitochondria, leading to mitochondrial dysfunction and apoptosis in T-cell acute lymphoblastic leukemia [147].”
BackgroundPatra, S., Praharaj, P. P., Klionsky, D. J., & Bhutia, S. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.08.004 · Cited by 71
Chen, Y., Liang, Y., Luo, X., & Hu, Q. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2488-y · Cited by 68
Metadata
- Authors
- Jing, B., Jin, J., Xiang, R., Liu, M., Yang, L., Tong, Y., Xiao, X., Lei, H., Liu, W., Xu, H., Deng, J., Zhou, L., & Wu, Y.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Deng, Jiong
- Zhou, Li
- Wu, Yingli
- ORCID
- Venue
- Cell Death & Disease
- Published
- 2018-05-22
- Volume
- 9
- Issue
- 6
- Pages
- 589-589
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC5964102
- OpenAlex
- W2803683563
- Cited by
- 38
- References
- 39
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 10 · 2020: 6 · 2019: 5
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81570118, 973 Program, 81570112, 2015CB910403, 2017YFA0505200)
- Shanghai Municipal Education Commission
- National Key Research and Development Program of China (2017YFA0505200, 2015CB910403)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- vorinostat, quinacrine, T-cell acute lymphoblastic leukemia, histone deacetylase inhibitors, drug synergy, reactive oxygen species, mitochondrial ubiquitination, apoptosis, Mcl-1, Bcl-2/Bax ratio, N-acetylcysteine, autophagy inhibition, xenograft mouse model
- MeSH terms
- Vorinostat, Animals, Cell Survival, Drug Synergism, Humans, Mitochondria, Models, Biological, Quinacrine, Mice, SCID, Mice, Inbred NOD, Apoptosis, Reactive Oxygen Species, Cell Line, Tumor, Cell Proliferation, Membrane Potential, Mitochondrial, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition. https://app.cochat.ai/papers/10.1038/s41419-018-0679-6
- The paper
- Jing, B., Jin, J., Xiang, R., Liu, M., Yang, L., Tong, Y., Xiao, X., Lei, H., Liu, W., Xu, H., Deng, J., Zhou, L., & Wu, Y. (2018). Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition. Cell Death & Disease. https://doi.org/10.1038/s41419-018-0679-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.